EUVIMEDEUVIMED entdecken
Vergleichsstudie

Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi‐Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor

Wolfgang Gruber, Jana Koop, Franziska A Haegele, Christian Falkenberg, Strefan Dewey, Burkhard Weisser, Anja Bosy-Westphal

Pediatric Pulmonology · 2025-04 · 60 (4)

DOI: 10.1002/ppul.71076 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Pulmonology, 2025-04. Verfasst von Wolfgang Gruber und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Nutrition and Food Science, Kiel University, Kiel, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Quinolones, Aminophenols, Benzodioxoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: This study has been financially supported by the Deutsche Rentenversicherung Nord (German Pension Fund), TBC Gesellschaft Schleswig-Holstein, and Mukoviszidose….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effects of CFTR modulators, particularly elexacaftor/tezacaftor/ivacaftor (ETI), on exercise capacity in people with cystic fibrosis (pwCF) remain unclear, with no data available on their impact within the context of an exercise intervention. Therefore, this study aimed to assess the effects of an exercise intervention on exercise capacity in adults with CF, comparing those treated with and without ETI.

Methods

A total of 56 adult pwCF participated in this quasi‐experimental study as part of a rehabilitation program, which included a 3.5‐week exercise intervention. The program involved five weekly 45‐min sessions, including endurance training on a cycle ergometer. VO 2 peak and W peak were the primary outcomes used to assess changes in exercise capacity.

Results

The intervention significantly increased VO 2 peak and W peak in all pwCF, regardless of ETI use, with similar improvements between groups. PwCF with lower baseline fitness (VO 2 peak ≤ 81%pred) showed greater improvements than those with higher fitness (VO 2 peak ≥ 82%pred). ppFEV1 remained unchanged, while BMI increased in both groups. Notably, the ETI group spent significantly more time in physical activity (PA) at hard and very hard intensities compared to the non‐ETI group. Additionally, a positive correlation was observed between PA intensity and VO 2 peak and W peak in the ETI group.

Conclusion

Independent of ETI treatment, adult pwCF improve their exercise capacity by participating in a regular exercise program. ETI treatment appears to enhance time spent in higher PA intensities. Despite the effectiveness of CFTR modulators, regular PA and exercise remain essential to maintain and improve exercise capacity in pwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisQuinolonesAminophenolsBenzodioxolesIndolesExercise ToleranceExercise TherapyPyrrolidinesPyrazolesPyridinesHumansMaleFemaleAdultDrug CombinationsYoung AdultTreatment OutcomeAdolescentChloride Channel AgonistsQuinolines

Stichwörter der Autor:innen

CFTR modulatorscystic fibrosiselexacaftor/tezacaftor/ivacaftor (ETI)exercise capacitytraining effects

Substanzen

QuinolonesAminophenolsBenzodioxolesIndolesDrug CombinationsivacaftorPyrrolidinesPyrazolesPyridineselexacaftor

Autor:innen und Institutionen

  • Institute of Human Nutrition and Food Science, Kiel University, Kiel, Germany.
  • Pediatric Pulmonology and Sleep Medicine, Cystic Fibrosis Center, Children's Hospital, University of Duisburg-Essen, Essen, Germany.
  • Fachklinik Sattelduene, Nebel/Amrum, Germany.
  • Strandklinik St. Peter Ording, St. Peter Ording, Germany.
  • Department Sports Medicine and Exercise Science, Insitute for Sports Science, Kiel University, Kiel, Germany.

Förderung

  • This study has been financially supported by the Deutsche Rentenversicherung Nord (German Pension Fund), TBC Gesellschaft Schleswig-Holstein, and Mukoviszidose…

Zitieren

APA

Gruber, W., Koop, J., Haegele, F. A., Falkenberg, C., Dewey, S., Weisser, B., & Bosy-Westphal, A. (2025). Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi‐Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor. Pediatric Pulmonology, 60(4). https://doi.org/10.1002/ppul.71076

Vancouver

Gruber W, Koop J, Haegele FA, Falkenberg C, Dewey S, Weisser B, et al. Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi‐Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor. Pediatric Pulmonology. 2025;60(4). doi:10.1002/ppul.71076

BibTeX
@article{Gruber2025,
  author = {Gruber, Wolfgang and Koop, Jana and Haegele, Franziska A and Falkenberg, Christian and Dewey, Strefan and Weisser, Burkhard and Bosy-Westphal, Anja},
  title = {Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi‐Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor},
  journal = {Pediatric Pulmonology},
  year = {2025},
  volume = {60},
  number = {4},
  doi = {10.1002/ppul.71076}
}
Kostenlos starten →